Japanese stem cell gene delivery breakthrough
This article was originally published in Scrip
Executive Summary
In a breakthrough which could aid the development of drug screening models and regenerative therapies, Japanese researchers have used a helper-dependent adenoviral vector to deliver genes to human embryonic stem cells with an efficiency of close to 100%. Typical efficiency for non-viral vectors is around 50% and several percent only for normal viral vectors. Helper-dependent vectors lack all viral coding sequences, minimising immunogenicity compared with common adenoviral vectors. Efficient gene delivery to pluripotent stem cells may allow better induction and control of differentiation into various cell types. The findings from Professor Kohnosuke Mitaniet al were published in the proceedings of the US National Academy of Sciences.
You may also be interested in...
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: the shifting sands of pharma R&D; big pharma oncology strategies; semaglutide’s promise in heart failure; AstraZeneca looks to multiple cancer modalities; and an interview with Astellas’s chief strategy officer.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Genmab buys into ADCs; Roivant set to take on AbbVie in uveitis; Ipsen signs firs ADC pact; South Korea looks to build biotech momentum; and the end of the road for Acorda.
Quick Listen: Scrip's Five Must-Know Things
In this week's podcast edition of Five Must-Know Things: Merck & Co progresses cardiovascular strategy; Novo purchase builds heart failure presence; CRL setbacks for Regeneron; ITF faces challenging Duchenne field; and AbbVie needs to freshen up.